A Medical Device Daily
Nanogen (San Diego) a developer of molecular-biology and rapid diagnostic products, and Thermo Fisher Scientific ( Waltham, Massachusetts) have entered into an agreement in which Thermo Fisher will be the exclusive provider of a variety of products used in gene-expression experiments. These products are based on Nanogen's second-generation probe technology for real-time polymerase chain reaction (PCR) applications.
The agreement covers both custom and standard catalog products based on Nanogen's technology for real-time PCR applications. This probe technology is used as a method of quantitative detection for specific DNA or RNA sequences in a biological sample and incorporates Nanogen's MGB (Minor Groove Binder) technology. The Minor Groove Binder is a crescent-shaped molecule that when coupled to an oligonucleotide probe stabilizes the detection-target duplex, improving efficiency and specificity compared to longer traditional probes.
Nanogen's MGB technology is license in various fields and is now a component in thousands of PCR probe products. Nanogen says it has more than 35 reagent and kit products that are sold for clinical diagnostic use under the MGB Alert and Q-PCR Alert brands.
In other agreements:
• Rivulet Communications (Herndon, Virginia) reported entering into a reseller agreement with ConMed Integrated Systems (Beaverton, Oregon), a provider Smart OR solution controls for the operating room, including data management, communication and networking capabilities.
The agreement entitles ConMed to resell the suite of Rivulet's networking products and enables ConMed to move high-definition, standard-definition and computer video out of the OR to locations throughout the hospital campus.
ConMed develops surgical equipment for minimally invasive procedures and monitoring.
• Siemens Healthcare (Malvern Pennsylvania) reported the addition of a mammography digitizing system from Carestream Healthcare (Rochester, New York) to its Accessory Solutions product portfolio. The digitizer is offered through Siemens to U.S. healthcare providers.
Carestream's digitizer enables mammography facilities to transition to digital imaging by converting prior film-based diagnostic and screening mammograms into a digital imaging format so they can be viewed in conjunction with digital mammography exams on a diagnostic workstation.
• Tornier (Edina, Minnesota) a developer of orthopaedics, and LifeCell (Branchburg, New Jersey) have entered into an exclusive distribution agreement of orthopedic and podiatric applications for LifeCell's new reconstructive tissue matrix.
The companies will collaborate in developing certain orthopedic soft tissue repair applications for which Tornier will distribute the product to its orthopaedic and podiatric surgeon customers under the Conexa brand. Currently, LifeCell markets and distributes the tissue matrix for general soft tissue repair applications under Strattice Reconstructive Tissue Matrix.
LifeCell said its animal studies and early clinical investigation in general soft tissue repair have demonstrated that the new porcine-derived tissue matrix performs essentially equivalent to its flagship human tissue matrix, AlloDerm, demonstrating that it allows for tissue regeneration.
Conexa tissue matrix is available sterile, ready to use, comes in multiple sizes and is an excellent option for orthopaedic soft tissue repair and reconstructive applications.
Tornier develops orthopedic devices.